Table 1.

Correlation between GLYAT expression level and clinicopathological features in patients with breast cancer.

Clinical characteristics	No. (n = 310)	GLYAT		P value
		Low (143)	High (167)
Age (years)
<50	139	59	80	0.241
≥50	171	84	87
Menopausal status
Premenopausal	165	73	92	0.477
Postmenopausal	145	70	75
Tumor Size (cm)
≤2	193	93	100	0.351
>2	117	50	67
Nodes status
Positive	102	41	61	0.142
Negative	208	102	106
TNM stage
I	128	40	68	0.033
II	133	64	69
III	49	39	30
Pathologic type
Invasive ductal carcinoma	202	97	105	0.361
Others	108	46	62
Histological grade
I	51	16	35	0.040
II	201	95	106
III	58	32	26
ER status
Positive	223	102	121	0.826
Negative	87	41	46
PR status
Positive	217	103	114	0.471
Negative	93	40	53
Her-2 status
Positive	45	19	26	0.570
Negative	265	124	141
Ki-67 status
High	91	50	41	0.045
Low	219	93	126
Molecular subtype
Luminal A	156	71	85	0.971
Luminal B	71	32	39
HER2 Positive	30	14	16
Triple Negative	53	26	27

GLYAT, Glycine N-acyltransferase; TNM, tumor-node-metastasis.